LKC Technologies
English
English Español Português 日本
  • Products
    • For Humans
      • RETeval
      • UTAS mf/PERG
      • Sensor Strips
    • For Animals
      • RETevet
      • Request Demo
      • Order Supplies
  • Applications
    • Visual Electrophysiology
      • Electroretinography (ERG)
      • Visual Evoked Potential (VEP)
    • Clinical Conditions
      • Diabetic Retinopathy
      • Glaucoma
      • Retinal Ischemic Diseases
      • Inherited Retinal Disorders
      • Miscellaneous
    • Animal Applications
  • Resources
    • Case Studies
    • eBooks & Reports
    • Webinars
    • Articles
    • Research
    • Blog
    • Videos
    • Software
  • About LKC
    • Vision & Mission
    • Team
    • Clinical Advisors
    • Testimonials
    • History
  • Contact
  • Eye Care Customers
  • VET Customers
  • Buy Sensor Strips
LKC Technologies Vision Defined TM

Webinar Four Recording

Aired: May 31, 2021 6:00 pm BST/ 1:00 PM ET

Women in visual electrophysiology

Effect of maternal opioid use during pregnancy on children's vision

Dr. Ruth Hamilton, PhD

PRESENTED BY:

Dr. Ruth Hamilton

In this fourth installment, Dr. Ruth Hamilton presents on her fascinating research using ERG to research the effects of prenatal opioid use on children’s vision.

  • Hamilton R, 2021: Clinical electrophysiology of vision-commentary on current status and future prospects.
  • Mactier H, Hamilton R, 2020: Prenatal opioid exposure - Increasing evidence of harm.
  • Monnelly VJ, Hamilton R, Chappell FM, Mactier H, Boardman JP, 2019. Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis.
  • McGlone L, Hamilton R, McCulloch DL, MacKinnon JR, Bradnam M, Mactier H, 2014: Visual outcome in infants born to drug-misusing mothers prescribed methadone in pregnancy.
  • McGlone L, Hamilton R, McCulloch DL, Boulton R, Bradnam MS, Weaver LT, Mactier H, 2013: Neonatal visual evoked potentials in infants born to mothers prescribed methadone.
  • Mactier H, McGlone L, Hamilton R, MacKinnon JR, 2012: Neonatal abstinence syndrome can be a problem.
  • Hamilton R, McGlone L, MacKinnon JR, Russell HC, Bradnam MS, Mactier H, 2010: Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy.

Imaging can't see everything... Go beyond with the RETeval® device.

sistema reteval ERG VEP

The RETeval® device is changing the way ERG/VEP testing is done, in clinics and in research alike.

Get the full picture of patient eye health with non-invasive, effective, and reliable testing – leading to better patient care and outcomes.

Dynamic pupillometry makes dilation optional for many tests, and patented sensor strips replace corneal electrodes — resulting in improved patient compliance and comfort for ERG testing.

Learn more about the RETeval® device 

Want to learn more?
Talk to us

  • Products
    • RETeval
    • UTAS mf/PERG
    • Sensor Strips
    • RETevet
  • Electrophysiology Tests
    • Electroretinography (ERG)
    • Full-Field ERG (ffERG)
    • Pattern ERG (PERG)
    • Multifocal ERG (mfERG)
    • Visual Evoked Potential (VEP)
    • Address2 Professional Drive, Suite 222
      Gaithersburg, MD 20879 USA
    • Phone+1 301 840 1992 (US & Canada)
      +358 40 8486625 (International)
    • International Distributors
      • Medical Device Distributors
      • Veterinary Device Distributors
  • Follow LKC Technologies on LinkedIn
  • Follow LKC Technologies on Facebook
  • Subscribe to LKC Technologies on YouTube
  • Follow LKC Technologies on Instagram
cropped-cropped-LKC_logo_RGB_color_no_tagline_mini_400px.png
© 2025 LKC Technologies, Inc.
  • Accessibility Statement
  • Terms & Conditions
  • Certifications
  • Privacy Policy
  • Careers

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity